Related Experiment Video
Updated: May 9, 2025

09:58
Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing
Published on: April 23, 2015
8.9K
Microrobotic Swarms for Cancer Therapy
Leiming Xie1,2, Jinbo Liu1,2, Zhen Yang1,2
1Shenzhen Institute of Artificial Intelligence and Robotics for Society (AIRS), Shenzhen 518129, China.
Research (Washington, D.C.)
|April 30, 2025
Summary
Microrobotic swarms offer a novel approach to cancer treatment, enabling precise cellular-level intervention with improved delivery and adaptability. This review explores their design, control, and therapeutic applications for revolutionizing cancer care.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Microrobotic swarms represent a significant advancement in cancer therapy.
- Their coordinated action allows for precise, cellular-level treatment.
- Existing research covers microrobot design, functionalization, and applications.
Purpose of the Study:
- To provide a comprehensive review of microrobotic swarms for cancer therapy.
- To explore microrobot design, focusing on tumor targeting, infiltration, and efficacy.
- To discuss advancements in active delivery and imaging for enhanced precision.
Main Methods:
- Review of existing literature on microrobotic swarms in cancer treatment.
- Analysis of microrobot design principles for therapeutic applications.
- Categorization and evaluation of different cancer therapies enabled by microrobotic swarms.
Main Results:
- Microrobotic swarms demonstrate enhanced delivery efficiency and environmental adaptability.
- Specific designs focus on improving tumor targeting, infiltration, and therapeutic outcomes.
- Active delivery methods and advanced imaging techniques increase system precision.
Conclusions:
- Microrobotic swarms hold immense potential to revolutionize cancer treatment strategies.
- Their application spans various cancer types, offering a new paradigm in oncological care.
- Further development promises more effective and targeted cancer therapies.

